togo y@serologic@kattwinkel j@reach@wright-p-f@infant@monitored@aap committee infect dis rept@evaluation@j clin psychopharmacol@thorax@children@safety@evaluated@respiratory@termeulen v@fully@smorodinstsev aa@ae@j pharmacol exp ther@carefully@j-infect-dis@mclaren c@amantadine@j pediatr@population@n engl j med@symptomatic@feigelson j@pediatr infect dis j@science@chanock rm@adolescence@viral@fibrosis@jama@becker y@adult@friend pa@male@biandrate p@infection@study@role@indicated@j roy soc med@am j dis child@strains@virus@pathogens@cystic-fibrosis@initial@biochemical@nouv presse med@co@prog med virol@j chromatogr@influenza respiratory disease@petersen nt@appearance@wang eel@fixation@did@shields wd@cystic@toxicity@tu@screening@acta paediatr scand@pediatr res@davies wl@trial@drug@pediatric@amantadine-hc1@support-u-s-govt-p-h-s@placebos@clinical-trials@hall cb@infections@variant@female@complement@potential@area@strain@new@england@viruses@epidemic@j med virol@patients@fishaut m@child-preschool@sever jl@sem respir med@important@aug@quilligan jj jr@tests@recommended method for the us@exacerbations@antiviral@virus-diseases@clinically@child@influenza@hoiby n@assessed@rev infect dis@respiratory-tract-infections@lancet@effective@shwachman-h@khaw-k-t@ambrosini pj@a/england/42@glezen wp@stroobant j@thompson j@human@double-blind@wingfield wl@neurology@acta path microbiol scand c s262@effectiveness@anon@bleidner we@disease@monatsschr kinderheilkd@efthimiou j@j infect@j immunol@mischler eh@pc@oxman-m-n@am j med@proportions@